TY  - BOOK
AU  - Ibrahim Mohammed Ahmed Abdulwahid Alsharabi
AU  - Ahmed Abdelbary Abdelrahman , 
AU  - Ahmed Abdelfatah Aboelwafa , 
TI  - A Pharmaceutical study on certain aminosalicylates / 
PY  - 2011///
CY  - Cairo : 
PB  - Ibrahim Mohammed Ahmed Abdulwahid Alsharabi , 
KW  - Colonic targeting
KW  - Mesalazine
KW  - Ulcerative colitis
N1  - Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Industrial Pharmacy; Issued also as CD
N2  - The recommended first - line therapy for the treatment of active symptoms induction of remission and maintenance of remission in patients with mild - to moderate ulcerative colitis (UC) is the anti inflammatory agent 5 - aminosalicylic acid (5- ASA or mesalazine ) . 5- ASA acts topically on the colonic mucosa but when orally administered it is extensively and rapidly absorbed in the small intestine
UR  - http://172.23.153.220/th.pdf
ER  -